54 results
Page 2 of 3
8-K
EX-99.2
mt53gihbnb yjt
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
b9gmf70nx
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
EX-99.1
6s2ub1kjjzd6s66i
14 Feb 22
Larimar Therapeutics Provides Update on CTI-1601 Clinical Program
12:00am
8-K
EX-99.2
36cb qs8mn
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
8-K
EX-99.1
c0ctrfdorusq8iu3vghd
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
8-K
EX-99.2
ynadmbgncp9e4av
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am
8-K
EX-99.1
r1f1bknfd
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am
8-K
EX-99.1
yalxyow15fsyar
1 Jul 21
Other Events
6:11am
8-K
EX-99.1
kmua1
14 Jun 21
Other Events
5:21pm
8-K
EX-99.1
29pck xmud7juohmlz97
26 May 21
Larimar Therapeutics Reports FDA Clinical Hold on CTI-1601 and Termination of Recently Announced Private Placement Financing
10:17am
8-K
EX-99.1
rhoxlw kl
21 May 21
Larimar Therapeutics Receives European Medicines Agency Priority Medicines (PRIME) Designation for CTI-1601 in Friedreich’s Ataxia
7:28am
8-K
EX-99.1
tywd3r90lyn steokp
18 May 21
Other Events
3:09pm
8-K
EX-99.1
mhx37qy am287w6eh7
11 May 21
Other Events
8:34am
8-K
EX-99.2
rx03e69
11 May 21
Other Events
8:34am
8-K
EX-99.1
uw9klh5x nswe
10 May 21
Larimar Therapeutics Reports First Quarter 2021 Operating and Financial Results
4:15pm
8-K
EX-99.1
0raj4o5
4 Mar 21
Larimar Therapeutics Reports Fourth Quarter and Full Year 2020 Operating and Financial Results
7:30am